Pluristem (PSTI) - Cash Flow Conversion Efficiency

Latest as of March 2022: -0.235x

Based on the latest financial reports, Pluristem (PSTI) has a cash flow conversion efficiency ratio of -0.235x as of March 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-9.42 Million ≈ $-25.26K USD) by net assets (ILA40.14 Million ≈ $107.62K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PSTI equity financing ratio to measure how much of total assets are equity-financed.

Pluristem - Cash Flow Conversion Efficiency Trend (2014–2021)

This chart illustrates how Pluristem's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore how much of Pluristem's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Pluristem Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pluristem ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
UNIQUE KLSE:0257	0.049x
LTKM Bhd KLSE:7085	0.118x
Malacca Trust Wuwungan Insurance PT JK:MTWI	-0.112x
Akme Fintrade India Ltd NSE:AFIL	-0.209x
E& Corporation CO. LTD KQ:066980	0.016x
Daiyang Metal KO:009190	-0.016x
Kristal Kola ve Mesrubat Sanayi Ticaret AS IS:KRSTL	0.061x
Equus Energy Ltd AU:EQU	-0.161x

Annual Cash Flow Conversion Efficiency for Pluristem (2014–2021)

The table below shows the annual cash flow conversion efficiency of Pluristem from 2014 to 2021. For the full company profile with market capitalisation and key ratios, see Pluristem market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2021-06-30	ILA57.15 Million ≈ $153.22K	ILA-30.91 Million ≈ $-82.87K	-0.541x	-15.07%
2020-06-30	ILA56.10 Million ≈ $150.40K	ILA-26.37 Million ≈ $-70.69K	-0.470x	+65.18%
2019-06-30	ILA21.82 Million ≈ $58.50K	ILA-29.45 Million ≈ $-78.96K	-1.350x	-79.97%
2018-06-30	ILA28.51 Million ≈ $76.43K	ILA-21.38 Million ≈ $-57.32K	-0.750x	-4.98%
2017-06-30	ILA30.25 Million ≈ $81.10K	ILA-21.61 Million ≈ $-57.94K	-0.714x	-47.17%
2016-06-30	ILA38.16 Million ≈ $102.29K	ILA-18.52 Million ≈ $-49.66K	-0.485x	-36.98%
2015-06-30	ILA58.14 Million ≈ $155.88K	ILA-20.61 Million ≈ $-55.24K	-0.354x	-15.14%
2014-06-30	ILA62.12 Million ≈ $166.55K	ILA-19.12 Million ≈ $-51.26K	-0.308x	--

About Pluristem

TA:PSTI Israel Biotechnology & Medical Research

Market Cap

$44.19 Million

ILA16.48 Billion ILA

Market Cap Rank

#22301 Global

#310 in Israel

Share Price

ILA509.50

Change (1 day)

-2.02%

52-Week Range

ILA501.00 - ILA1831.00

All Time High

ILA72010.00